Merck Makes Deal to Develop Schizophrenia Drug
15688
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
758408
WASHINGTON -- The Food and Drug Administration on Wednesday approved a widely used adult psychiatric drug for the treatment of schizophrenia and bipolar disorder in children and adolescents.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.
229941
Indianapolis-based Eli Lilly and Company and Merck KGaA of Darmstadt, Germany, announced today that Lilly has acquired Merck&#39;s 5-HT2a antagonist compound EMD 281014, a potential breakthrough treatment for insomnia.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
254822
In a clinical trial of about 200 patients, an experimental drug from Eli Lilly lessened schizophrenia symptoms without the serious side effects of current treatments, according to a paper published Sunday in the journal Nature.
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
624821
NEW YORK -- Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
523577
Drug maker Eli Lilly and Co. said Wednesday that it acquired the rights to an insomnia treatment developed by Germany pharmaceutical company Merck KGaA.
103036
A trial of a new type of schizophrenia drug shows promise in patients.
110719
German drugmaker Merck MRCG.DE on   Thursday agreed to buy a 64.5 percent stake in rival Serono   SEO.VX in a surprise deal valued over 10 billion Swiss francs   ($8.3 billion), creating a new force in European   pharmaceuticals.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
374648
A schizophrenia drug from Johnson & Johnson won U.S. approval as the first medicine to treat symptoms of autism in children and adolescents, the Food and Drug Administration said on Friday.
125992
Merck has obtained rights to license an experimental anti-obesity drug that is based on a hormone the body uses to signal that it has eaten enough.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
218831
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise $13.3 billion deal to buy   Europe's biggest biotech firm Serono SEO.VX on Thursday,   creating a new force in European pharmaceuticals.